Skip to main content

Capital Research Global Investors

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1422848 Los Angeles, CA

Position in TAK

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$353,810,135
+$143,551,360 QoQ
Shares Held
19,104,219
+41.7% QoQ
Ownership
0.605%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Capital Research Global Investors holds $573,348,010 across 3 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (61.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TAK
Takeda Pharmaceutical Co Ltd
This page
19,104,219 $353,810,135

All Filings in TAK

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $353,810,135 19,104,219
2025-12-31 $210,258,775 13,486,772
2025-09-30 $196,236,448 13,404,129
2025-06-30 $205,549,558 13,295,573
2025-03-31 $196,298,929 13,201,004
2024-12-31 $174,271,672 13,162,513
2024-09-30 $186,811,040 13,137,204
2024-06-30 $169,858,307 13,126,608
2024-03-31 $182,263,607 13,121,930
2023-12-31 $204,029,677 14,297,805
2023-09-30 $213,398,733 13,794,359
2023-06-30 $216,606,982 13,787,841
2023-03-31 $223,789,500 13,579,460
2022-12-31 $41,747,737 2,676,137
2020-12-31 $1,190,826 65,430
2020-09-30 $987,890 55,375
2020-06-30 $920,400 51,333
2020-03-31 $541,333 35,661